Are there clinical features that would lead you to consider combining SBRT + immunotherapy in a high risk early stage NSCLC?  

Answer from: Radiation Oncologist at Academic Institution
Medical Oncologist at NYU Winthrop Hospital
Only clinical trials.
Radiation Oncologist at Cancer Care Centers of Brevard
Clinical trial question. 
Sign in or Register to read more